Journal of Family and Reproductive Health最新文献

{"title":"Erratum.","authors":"","doi":"10.18502/jfrh.v17i4.14667","DOIUrl":"https://doi.org/10.18502/jfrh.v17i4.14667","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.18502/jfrh.v17i3.13542.].</p>","PeriodicalId":15845,"journal":{"name":"Journal of Family and Reproductive Health","volume":"17 4","pages":"270"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11128736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Root-Cause Analysis of Maternal Mortality in Fars Province, Southern Iran 2014: Negligence Is the Prime Suspect.","authors":"Alireza Mirahmadizadeh,&nbsp;Ali Semati,&nbsp;Babak Eshrati,&nbsp;Fariba Moradi,&nbsp;Nasrin Asadi","doi":"10.18502/jfrh.v14i3.4669","DOIUrl":"https://doi.org/10.18502/jfrh.v14i3.4669","url":null,"abstract":"Objective: we aimed to carry out an applied methodological tool, using Root-Cause Analysis (RCA), to determine the main causes of maternal mortality in Fars province, south of Iran, in 2014. Materials and methods: This is a case-series study and was conducted based on a careful examination of records and verbal autopsy with the family of the deceased person and their medical care team. Using RCA, quantitative dynamic modeling was done to display the overall impacts of different causes on maternal mortality. Finally, sensitivity analysis was done to determine the magnitude of contribution of each root-cause of maternal mortality. Results: Totally, all 10 maternal deaths with Maternal Mortality Rate (MMR) of 13.4 per 100.000 births, were recorded in the maternal surveillance system during 2014. The RCA results revealed that the root-causes of maternal mortality were ignorance and negligence (50%), delay in diagnosis (30%), delay in service provision in the first 24 hours after delivery (10%), and undesirable health care (10%). The results of sensitivity analysis in different scenarios revealed that medical negligence had the highest contribution to maternal mortality. Conclusion: Although maternal surveillance system stated some causes such as hemorrhage to be responsible for maternal deaths, the RCA showed that root-causes such as medical neglects had a fundamental role. Therefore, maternal mortality can be prevented by reforming the health care system and training all service providers, especially for high-risk mothers.","PeriodicalId":15845,"journal":{"name":"Journal of Family and Reproductive Health","volume":" ","pages":"166-172"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7c/43/JFRH-14-166.PMC7868652.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25382045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lifestyle and Comorbidities: Do We Take Enough Care of Preconception Health in Assisted Reproduction?","authors":"Michela Cirillo, Maria Elisabetta Coccia, Cinzia Fatini","doi":"10.18502/jfrh.v14i3.4667","DOIUrl":"10.18502/jfrh.v14i3.4667","url":null,"abstract":"<p><p><b>Objective:</b> The preconception period is largely neglected, whereas it represents an opportunity to identify and modify clinical and behavioral risks, particularly in infertile women characterized by an unfavorable vascular burden. The present study was performed to strengthen previous findings and to increase the awareness of clinicians who should envision a broader preconception approach in infertile women, beyond their reproductive health. <b>Materials and methods:</b> In this cross-sectional study, we investigated 1003 Caucasian women, referred to the Internal Medicine Clinic at the Assisted Reproductive Technologies Center, Florence. <b>Results:</b> A high prevalence of dyslipidemia (57.4%), overweight/obesity (29.1%) and, smoking habit (26.6%) were found. We provided evidence of unhealthy lifestyle habits, represented by a closer adherence to the Mediterranean diet in the 9.5% only and by a sedentary behavior in 73%. A significant correlation between the Mediterranean Diet score and both anthropometric and metabolic parameters was found. We also observed a lower score adherence with both metabolic syndrome and diabetes (for both p=0.02), but not with hypertension. <b>Conclusion:</b> Before infertility treatment, the correction and the management of modifiable and non-modifiable cardiovascular risk factors are mandatory and represent the main goal for a safe pregnancy, and lifetime women's health.</p>","PeriodicalId":15845,"journal":{"name":"Journal of Family and Reproductive Health","volume":" ","pages":"150-157"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a6/c8/JFRH-14-150.PMC7868650.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25387644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparing the Effectiveness of Doing Intra-uterine Insemination 36 and 42 Hours After Human Chorionic Gonadotropin (HCG) Injection on Pregnancy Rate: A Randomized Clinical Trial.","authors":"Mahboubeh Firouz,&nbsp;Narjes Noori,&nbsp;Marzieh Ghasemi,&nbsp;Alireza Dashipour,&nbsp;Narjes Keikha","doi":"10.18502/jfrh.v14i3.4670","DOIUrl":"https://doi.org/10.18502/jfrh.v14i3.4670","url":null,"abstract":"<p><p><b>Objective:</b> Intrauterine insemination (IUI) is an assisted conception technique that involves the deposition of a processed semen sample in the upper uterine cavity, overcoming natural barriers to sperm ascent in the female reproductive tract. Hence, we compared the results of doing intra-uterine insemination 36 and 42 hours after human chorionic gonadotropin (hCG) hormone injection to achieve clinical and chemical pregnancy rates. <b>Materials and methods:</b> One hundred and sixty infertile women with unexplained infertility participated in this clinical trial. They were divided into two groups: those who underwent IUI 36 hours after hCG injection (control group), and those who underwent IUI 42 hours after hCG injection (case group). Statistical analyses were done using IBM-SPSS 25.0. and Chi-square test were used for data analysis. <b>Results:</b> The percentages of clinical and chemical pregnancies were significantly higher in the 42h group compared to the other group (P = 0.038 vs. P = 0.009, respectively). There was no significant difference regarding frequency of abortion, twin and ectopic pregnancies between the two groups (P > 0.05). <b>Conclusion:</b> Doing IUI 42 hours after hCG injection can significantly increase chances of fertility compared to doing it 36 hours after hCG injection.</p>","PeriodicalId":15845,"journal":{"name":"Journal of Family and Reproductive Health","volume":" ","pages":"173-179"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2c/53/JFRH-14-173.PMC7868649.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25382046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Complementary and Alternative Medicine Usage and Its Determinant Factors Among Infertile Men in Iran.","authors":"Fatemeh Ghaedi Heidari,&nbsp;Mahlagha Dehghan,&nbsp;Sima Mokhtarabadi","doi":"10.18502/jfrh.v14i3.4671","DOIUrl":"https://doi.org/10.18502/jfrh.v14i3.4671","url":null,"abstract":"<p><p><b>Objective:</b> This study aimed to assess the use of some Complementary and Alternative Medicine (CAM) techniques in infertile men. <b>Materials and methods:</b> This cross-sectional study was conducted on 102 infertile men referred to the only center of infertility in Kerman, Iran using convenience sampling. Data were collected using a two-part researcher-made questionnaire and analyzed using descriptive and analytical statistics (chi-square test and logistic regression) with SPSS 16. <b>Results:</b> According to the present study, 72.5% of subjects used at least one of the CAM methods in the past year. Among them 28.4% of the subjects have used one CAM technique, 13.7% have used two techniques, 8.8% have used three techniques, 9.8% have used four techniques, and 11.8% have used more than four techniques since the last year. None of the socio-demographic characteristics had significant association with being the user of complementary and alternative medicines. <b>Conclusion:</b> The results showed that almost three quarters of the infertile men used CAM indicating a high prevalence of CAM usage among them.</p>","PeriodicalId":15845,"journal":{"name":"Journal of Family and Reproductive Health","volume":" ","pages":"180-185"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3c/2f/JFRH-14-180.PMC7868654.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25382047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Molar Changes With a Normal Viable Fetus: A Case Report.","authors":"Marjaneh Farazestanian,&nbsp;Asieh Maleki,&nbsp;Somayeh Bolandi,&nbsp;Zohreh Yousefi,&nbsp;Malihe Hasanzadeh,&nbsp;Laya Shirinzadeh,&nbsp;Sara Kamandi","doi":"10.18502/jfrh.v14i3.4675","DOIUrl":"https://doi.org/10.18502/jfrh.v14i3.4675","url":null,"abstract":"<p><p><b>Objective:</b> The presence of a normal fetus with normal karyotype accompanied by molar changes in the placenta is a rare condition, which carries a significant risk to the mother and fetus. There is a controversy regarding the proper management of this condition. Here, we present the case of a singleton pregnancy that showed molar changes in the pathological study of the placenta, but ended up with a normal viable neonate. <b>Case Report:</b> A 23-year-old primigravida woman, with a 3-year history of infertility, presented with vaginal bleeding and spotting. Her ß-human chorionic gonadotropin (HCG) at 13^th week was 36500 mIU/ml. Serial sonography assessments were suggestive for molar changes and a normal fetus with growth retardation but normal Doppler assessment. The patient underwent elective Cesarean section at 37 weeks gestation and a healthy female neonate with an Apgar score of 9-10, weighing 2270 g was born. Pathological assessment of the placenta confirmed the diagnosis of incomplete hydatidiform mole. After two months, the mother had no complications, her ß-HCG level was untraceable, and the infant was in good condition. <b>Conclusion:</b> Despite being a rare condition, partial moles can be accompanied by delivery of a normal fetus. The management of this condition still remains challenging and should be done under close monitoring with extreme caution.</p>","PeriodicalId":15845,"journal":{"name":"Journal of Family and Reproductive Health","volume":" ","pages":"205-208"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/82/JFRH-14-205.PMC7868656.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25382051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women's General Hospital.","authors":"Mojgan Asadi,&nbsp;Fatemeh Molavi,&nbsp;Mostafa Qorbani,&nbsp;Fatemeh Davari Tanha","doi":"10.18502/jfrh.v14i3.4672","DOIUrl":"https://doi.org/10.18502/jfrh.v14i3.4672","url":null,"abstract":"<p><p><b>Objective:</b> To evaluate the efficacy of Zolpidem and Nigella sativa compared to placebo in treatment of sleep disturbance in healthy postmenopausal women. Menopause is a period that diagnosed after 12 months of amenorrhea and is characterized by a group of symptoms that include irregular menses; vasomotor and urogenital symptoms. The effects of non-hormonal therapies are being widely researched on menopause symptoms. There has been no study to compare Zolpidem and Nigella sativa versus placebo. <b>Materials and methods:</b> In this double-blind, placebo controlled trial, we compared the effect of Zolpidem with Nigella sativa and placebo in reducing sleep quality in 60 menopausal women. The prior and the later results were compared. We divided the patients into three groups after history taking and physical examination and filling the Pittsburgh questionnaire. Each group received their medication as the following order: Group A: Zolpidem, Group B: Nigella sativa, Group C: placebo. The first group received Zolpidem with the dose of 5 mg for 8 weeks. The second group received Nigella sativa with the dose of 600 mg for 8 weeks. The third group received placebo for 8 weeks. After two months, the Pittsburg questionnaire was filled again. <b>Results:</b> In the nigella sativa group, we had not significant improvement in sleep quality (p =0.07), hot flashes (p =0.15), palpitation (p =0.56) and night sweets (p =0.08). In zolpidem group, we have seen lack of improvement of hot flashes (p =0.73), and palpitation (p =0.36), which are nonsignificant statistically according to p values, but in zolpidem group, we had significant improvement in sleep quality (p =0.01), and night sweats (p =0.049). <b>Conclusion:</b> It seems that zolpidem has some effect on improving the quality of sleep in postmenopausal women. zolpidem also is good for night sweats. Nigella sativa was not effective in vasomotor symptoms and sleep quality.</p>","PeriodicalId":15845,"journal":{"name":"Journal of Family and Reproductive Health","volume":" ","pages":"186-191"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d3/ac/JFRH-14-186.PMC7868655.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25382048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Shared Decision-making on Anxiety of Women Recommended for Prenatal Screening Tests in Southeast of Iran.","authors":"Zahra Moudi,&nbsp;Raheleh Jam,&nbsp;Hossein Ansari,&nbsp;Mostafa Montazer Zohour","doi":"10.18502/jfrh.v14i3.4673","DOIUrl":"https://doi.org/10.18502/jfrh.v14i3.4673","url":null,"abstract":"<p><p><b>Objective:</b> To study the effect of shared decision-making (SDM) on the anxiety of women who were recommended for prenatal screening tests. <b>Materials and methods:</b> This quasi-experimental study was conducted on a total of 200 pregnant women who referred to the health centers of Zahedan, Iran, for prenatal care within April 7 to September 7, 2019. The control group received routine care, and the intervention group attended a session based on SDM. The demographic characteristics form and Spielberger Six-item State-Trait Anxiety Inventory were filled out before and immediately after the counseling, as well as before receiving the results of maternal serum biochemical markers. <b>Results:</b> No statistically significant effect of SDM on anxiety was reported between the control and intervention groups immediately after the counseling session (P=0.46). However, the obtained data showed that the mean value of anxiety scores (16.52±3.06) was higher among the women in the intervention group than that reported for the control group (13.80±3.55) on the day before receiving the results of the blood tests (P<0.001). Nevertheless, logistic regression analysis showed only women with a university level of education were likely to have higher anxiety scores than women with lower educational levels (AOR=10.60; 95% CI: 2.07-54.24; P=0.005). <b>Conclusion:</b> Offering prenatal screening can cause a slight increase in the level of anxiety among women with a university level of education. Therefore, it is required to implement supportive strategies to help high-risk pregnant women in coping with anxiety.</p>","PeriodicalId":15845,"journal":{"name":"Journal of Family and Reproductive Health","volume":" ","pages":"192-197"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/79/JFRH-14-192.PMC7868651.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25382049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Pregnancy After Elimination of Embryo Fragments Before Fresh Cleavage-stage Embryo Transfer.","authors":"Luis H Sordia-Hernandez,&nbsp;Felipe A Morales-Martinez,&nbsp;Lorna M Frazer-Moreira,&nbsp;Lilith Villarreal-Pineda,&nbsp;María Ofelia Sordia-Piñeyro,&nbsp;Otto H Valdez-Martinez","doi":"10.18502/jfrh.v14i3.4674","DOIUrl":"https://doi.org/10.18502/jfrh.v14i3.4674","url":null,"abstract":"<p><p><b>Objective:</b> To determine if the elimination of fragments in cleavage-stage embryos, before fresh transfer, improves pregnancy rates in <i>in vitro</i> fertilization cycles. <b>Materials and methods:</b> This is a Prospective observational case-control study carried out at a University Reproductive Center. We included Twenty-six infertile patients divided into two groups. Group one: 13 patients with embryos classified as grade B and C (embryos with fragments) according to the Hill classification, and Group two: 13 patients with grade A embryos (embryos with no fragments). Embryo Defragmentation was performed in embryos of group one 65 to 68 hours after conventional fertilization. Fresh embryo transfer was made after two hours post fragments removal. Reproductive results were evaluated and compared between both groups. <b>Results:</b> The total number of clinical pregnancies was nine. In group one there were 5 (38.5 %); in group two, there were 4 (30.8%). The difference was not statistically significant (<i>p</i> = 0.68). Two abortions were reported in the study, both in group one; were fragment elimination was performed. This represents an abortion rate of 40% in patients who got pregnant in this group. These patients had twice the probability of suffering an abortion (OR 2.1; 95% CI 1.4-3.37). Ongoing pregnancies were similar in both groups. <b>Conclusion:</b> Removal of fragments in freshly transferred day three embryos could be an alternative to increase clinical pregnancy and ongoing pregnancy rates in patients who have only poor-quality embryos. Despite the relationship with a higher abortion rate, this strategy could represent a real alternative for this type of patient.</p>","PeriodicalId":15845,"journal":{"name":"Journal of Family and Reproductive Health","volume":" ","pages":"198-204"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b6/2e/JFRH-14-198.PMC7868653.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25382050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Supplement Usage Pattern in a Group of COVID- 19 Patients in Tehran.","authors":"Maryam Bagheri, Fedyeh Haghollahi, Mamak Shariat, Mina Jafarabadi, Parastoo Aryamloo, Elahe Rezayof","doi":"10.18502/jfrh.v14i3.4668","DOIUrl":"10.18502/jfrh.v14i3.4668","url":null,"abstract":"<p><p><b>Objective:</b> The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection, causes severe acute respiratory syndrome and was spread throughout the world in early 2020. The effects of vitamin and micronutrient supplements on the prevention and treatment of COVID- 19 seems challenging in scientific considerations. On the other side generally, experts warn against over-consumption of these supplements. <b>Materials and methods:</b> This study aimed to investigate the vitamin and micronutrient supplementation usage pattern in past history of patients with COVID-19 via a cross-sectional inquiry. Totally 510 patients referring to the infectious disease clinic of Imam Khomeini Hospital in Tehran from March 2020 to May 2020 were recruited. The inclusion criterion was suspected patients for COVID-19 based on clinical findings and CT scans of the lung. The infected patients included both inpatients (171) and outpatients (339). Demographic information, clinical signs, and the supplement pattern use were collected through a questionnaire and the data were statistically analyzed. <b>Results:</b> Vitamin D3 intake was reported in 30% (103 patients) of outpatients and 16.5% (28 patients) of hospitalized patients, which is statistically significant (P=0.001). It shows that, the frequency of vitamin D3 consumption in the outpatient group was higher than inpatient group. This significant difference has also been shown in zinc consumption, in 29 patients (9%) outpatients versus 4 patients (2%) inpatients were reported (P=0.007). Multi nominal regression showed that vitamin D3 intake has a supportive effect and reduces the risk of exacerbation and worsening of the disease. (OR=0.291; 95% CI 0.102-.0834, P=0.022). <b>Conclusion:</b> According to the results of the present study and the findings of other studies, considering the supportive effect of vitamin D3 in reducing the severity of infectious diseases; Clinical trials with an appropriate sample size are recommended to investigate the functional role of this vitamin in improving viral diseases of the respiratory tract.</p>","PeriodicalId":15845,"journal":{"name":"Journal of Family and Reproductive Health","volume":" ","pages":"158-165"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d4/da/JFRH-14-158.PMC7868648.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25382044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}